Literature DB >> 20505979

The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells.

Vladimír Cermák1, Jan Kosla, Jirí Plachý, Katerina Trejbalová, Jirí Hejnar, Michal Dvorák.   

Abstract

Metastatic spreading of cancer cells is a highly complex process directed primarily by the interplay between tumor microenvironment, cell surface receptors, and actin cytoskeleton dynamics. To advance our understanding of metastatic cancer dissemination, we have developed a model system that is based on two v-src transformed chicken sarcoma cell lines-the highly metastatic parental PR9692 and a non-metastasizing but fully tumorigenic clonal derivative PR9692-E9. Oligonucleotide microarray analysis of both cell lines revealed that the gene encoding the transcription factor EGR1 was downregulated in the non-metastatic PR9692-E9 cells. Further investigation demonstrated that the introduction of exogenous EGR1 into PR9692-E9 cells restored their metastatic potential to a level indistinguishable from parental PR9692 cells. Microarray analysis of EGR1 reconstituted cells revealed the activation of genes that are crucial for actin cytoskeleton contractility (MYL9), filopodia formation (MYO10), the production of specific extracellular matrix components (HAS2, COL6A1-3) and other essential pro-metastatic abilities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505979     DOI: 10.1007/s00018-010-0395-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  52 in total

Review 1.  Exploring expression data: identification and analysis of coexpressed genes.

Authors:  L J Heyer; S Kruglyak; S Yooseph
Journal:  Genome Res       Date:  1999-11       Impact factor: 9.043

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

3.  Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1.

Authors:  O Tournay; R Benezra
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

Review 4.  Matrix metalloproteinases and tumor metastasis.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

5.  Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells.

Authors:  Melanie A Simpson; Christopher M Wilson; Leo T Furcht; Andrew P Spicer; Theodore R Oegema; James B McCarthy
Journal:  J Biol Chem       Date:  2002-01-14       Impact factor: 5.157

6.  Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces.

Authors:  Daniel Rösel; Jan Brábek; Ondrej Tolde; Claudia T Mierke; Daniel P Zitterbart; Carina Raupach; Krisýtyna Bicanová; Philip Kollmannsberger; Daniela Panková; Pavel Vesely; Petr Folk; Ben Fabry
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

7.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

Review 8.  Roles of TGFbeta in metastasis.

Authors:  David Padua; Joan Massagué
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

9.  Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression.

Authors:  K J Daniels; H C Boldt; J A Martin; L M Gardner; M Meyer; R Folberg
Journal:  Lab Invest       Date:  1996-07       Impact factor: 5.662

10.  Interleukin-1 beta-induced Id2 gene expression is mediated by Egr-1 in vascular smooth muscle cells.

Authors:  Xiaojun Zhu; Yiming Lin; Methode Bacanamwo; Lin Chang; Rui Chai; Ivana Massud; Jifeng Zhang; Minerva T Garcia-Barrio; Winston E Thompson; Yuqing E Chen
Journal:  Cardiovasc Res       Date:  2007-06-22       Impact factor: 10.787

View more
  13 in total

Review 1.  Myosin-X and disease.

Authors:  David S Courson; Richard E Cheney
Journal:  Exp Cell Res       Date:  2015-03-27       Impact factor: 3.905

2.  Podocyte histone deacetylase activity regulates murine and human glomerular diseases.

Authors:  Kazunori Inoue; Geliang Gan; Maria Ciarleglio; Yan Zhang; Xuefei Tian; Christopher E Pedigo; Corey Cavanaugh; Janet Tate; Ying Wang; Elizabeth Cross; Marwin Groener; Nathan Chai; Zhen Wang; Amy Justice; Zhenhai Zhang; Chirag R Parikh; Francis P Wilson; Shuta Ishibe
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

3.  EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF.

Authors:  Gabi Tarcic; Roi Avraham; Gur Pines; Ido Amit; Tal Shay; Yiling Lu; Yaara Zwang; Menachem Katz; Nir Ben-Chetrit; Jasmine Jacob-Hirsch; Laura Virgilio; Gideon Rechavi; George Mavrothalassitis; Gordon B Mills; Eytan Domany; Yosef Yarden
Journal:  FASEB J       Date:  2011-12-23       Impact factor: 5.191

4.  Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis.

Authors:  Dov Hershkovitz; Yonit Gross; Sagi Nahum; Shiran Yehezkel; Ofer Sarig; Jouni Uitto; Eli Sprecher
Journal:  J Invest Dermatol       Date:  2010-12-16       Impact factor: 8.551

5.  Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.

Authors:  Antti Arjonen; Riina Kaukonen; Elina Mattila; Pegah Rouhi; Gunilla Högnäs; Harri Sihto; Bryan W Miller; Jennifer P Morton; Elmar Bucher; Pekka Taimen; Reetta Virtakoivu; Yihai Cao; Owen J Sansom; Heikki Joensuu; Johanna Ivaska
Journal:  J Clin Invest       Date:  2014-03       Impact factor: 14.808

6.  Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis.

Authors:  R Cao; J Chen; X Zhang; Y Zhai; X Qing; W Xing; L Zhang; Y S Malik; H Yu; X Zhu
Journal:  Br J Cancer       Date:  2014-06-12       Impact factor: 7.640

7.  Computational identification of surrogate genes for prostate cancer phases using machine learning and molecular network analysis.

Authors:  Rudong Li; Xiao Dong; Chengcheng Ma; Lei Liu
Journal:  Theor Biol Med Model       Date:  2014-08-23       Impact factor: 2.432

8.  Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma.

Authors:  Jian-Hua Wang; Lan Zhang; Shu-Ting Huang; Jing Xu; Yun Zhou; Xing-Juan Yu; Rong-Zhen Luo; Zhe-Sheng Wen; Wei-Hua Jia; Min Zheng
Journal:  PLoS One       Date:  2017-04-07       Impact factor: 3.240

9.  Metastasis of aggressive amoeboid sarcoma cells is dependent on Rho/ROCK/MLC signaling.

Authors:  Jan Kosla; Daniela Paňková; Jiří Plachý; Ondřej Tolde; Kristýna Bicanová; Michal Dvořák; Daniel Rösel; Jan Brábek
Journal:  Cell Commun Signal       Date:  2013-07-30       Impact factor: 5.712

10.  Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.

Authors:  Filip Mundt; Henrik J Johansson; Jenny Forshed; Sertaç Arslan; Muzaffer Metintas; Katalin Dobra; Janne Lehtiö; Anders Hjerpe
Journal:  Mol Cell Proteomics       Date:  2013-12-20       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.